RVPH · Reviva Pharmaceuticals Holdings, Inc. · Executive Compensation
$0.39
+0.04 (+10.76%)
At close · May 14
Return incl. dividend (before tax)
Going-concern doubt
— flagged Nov 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These conditions raise substantial doubt regarding the Company’s ability to continue as a going concern for a period of one year after the date the consolidated financial statements are issued.”View the 10-Q filed Nov 13, 2026
Market Cap
$6.33M
Shares
13.11M
Volume · May 14
742.02K
Avg daily vol (48 sessions)
985.8K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Laxminarayan Bhat | Chief Executive Officer and President | $1,442,121 |
| Narayan Prabhu | Chief Financial Officer | $659,670 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Laxminarayan Bhat | Chief Executive Officer and President | $607,500 |
| Narayan Prabhu | Chief Financial Officer | $404,950 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Laxminarayan Bhat | Chief Executive Officer and President | $2,764,747 |
| Narayan Prabhu | Chief Financial Officer | $1,248,778 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Laxminarayan Bhat | Chief Executive Officer and President | $560,000 |
| Narayan Prabhu | Chief Financial Officer | $412,500 |
| Marc Cantillon | Former Chief Medical Officer | $348,587 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Laxminarayan Bhat | Chief Executive Officer and President | $600,054 |
| Marc Cantillon | Former Chief Medical Officer | $501,981 |
| Narayan Prabhu | Chief Financial Officer | $437,134 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Laxminarayan Bhat | Chief Executive Officer and President | $247,952 |
| Marc Cantillon | Former Chief Medical Officer | $46,042 |
| Narayan Prabhu | Chief Financial Officer | $45,304 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Laxminarayan Bhat | Chief Executive Officer and President | $240,000 |
| Narayan Prabhu | Chief Financial Officer | — |
| Marc Cantillon | Chief Medical Officer | — |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
|
Marc Cantillon
“Dr. Cantillon’s resignation was not due to any disagreements with respect to the Company’s operations, policies or practices.”
|
Chief Medical Officer | Resigned | 2022-06-27 |
Leadership
- Laxminarayan Bhat CEO, Board Member
- Parag Saxena Chairman
- Narayan Prabhu CFO
- Les Funtleyder Board Member
- Purav Patel Board Member
- Richard Margolin Board Member
- To approve Board Member
Key facts
CIK
1742927
CUSIP
76152G209
13F (30d)
15 filings
4 filers
Visit website
Investor relations